Predictive markers and driving factors behind Richter syndrome development

Expert Review of Anticancer Therapy

Volumn 11, Issue 3, 2011, Pages 433-442

  Fangazio, Marco ^a   De Paoli, Lorenzo ^a   Rossi, Davide ^a   Gaidano, Gianluca ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

B cell receptor; CD38; chronic lymphocytic leukemia; del13q14; diffuse large B cell lymphoma; genetic lesions; IGHV genes; prognostic factors; Richter syndrome

Indexed keywords

CD38 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN HEAVY CHAIN VARIABLE REGION[4-39]; UNCLASSIFIED DRUG;

ACUTE LEUKEMIA; CANCER STAGING; CELL PROLIFERATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LARGE CELL LYMPHOMA; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; MOLECULAR PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PROGNOSIS; REVIEW; RICHTER SYNDROME; RISK FACTOR; TUMOR VOLUME;

ANTIGENS, CD38; CHROMOSOMES, HUMAN, PAIR 13; DISEASE PROGRESSION; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; PROGNOSIS; RISK FACTORS;

EID: 79952963276     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.10.237     Document Type: Review

References (75)

1. Richter MN. Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukaemia. Am. J. Pathol. 4(4), 285-292 (1928)
2. Hallek M, Cheson BD, Catovsky D, et al. International Workshop on Chronic Lymphocytic Leukemia. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute Working Group 1996 guidelines. Blood 111(12), 5446-5456 (2008)
3. Rossi D, Cerri M, Capello D, Deambrogi C, et al. Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. Br. J. Haematol. 142(2), 202-215 (2008) (Pubitemid 351987315)
4. Tsimberidou A-M, Keating MJ. Richter syndrome. Biology, incidence, and therapeutic strategies. Cancer 103(2), 216-228 (2005) (Pubitemid 40129279)
5. Maddocks-Christianson K, Slager SL, Zent CS, et al. Risk factors for development of a second malignancy in patients with chronic lymphocytic leukaemia. Br. J. Haematol. 139(3), 398-404 (2007) (Pubitemid 47512176)
6. Cherepakhin V, Baird SM, Meisenholder GW, Kipps TJ. Common clonal origin of chronic lymphocytic leukemia and high grade lymphoma of Richter's syndrome. Blood 82(10), 3141-3147 (1993) (Pubitemid 23334942)
7. Matolcsy A, Inghirami G, Knowles DM. Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma). Blood 83(5), 1363-1372 (1994) (Pubitemid 24062860)
8. Nakamura N, Kuze T, Hashimoto Y, et al. Analysis of the immunoglobulin heavy chain gene of secondary diffuse large B-cell lymphoma that subsequently developed in four cases with B-cell chronic lymphocytic leukemia or lymphoplasmacytoid lymphoma (Richter syndrome). Pathol. Int. 50(8), 636-643 (2000)
9. Timár B, Fülöp Z, Csernus B, et al. Relationship between the mutational status of VH genes and pathogenesis of diffuse large B-cell lymphoma in Richter's syndrome. Leukemia 18(2), 326-330 (2004) (Pubitemid 38240049)
10. Smit LA, van Maldegem F, Langerak AW, et al. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation. Haematologica 91(7), 903-911 (2006) (Pubitemid 44023143)
11. Mao Z, Quintanilla-Martinez L, Raffeld M, et al. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Am. J. Surg. Pathol. 31(10), 1605-1614 (2007) (Pubitemid 47482476)
12. O?Brien SM, Kantarjian HM, Thomas DA, et al. Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia. Cancer 98(12), 2657-2663 (2003) (Pubitemid 37509530)
13. Janssens A, Berth M, De Paepe P, et al. EBV negative Richter's syndrome from a coexistent clone after salvage treatment with alemtuzumab in a CLL patient. Am. J. Hematol. 81(9), 706-712 (2006) (Pubitemid 44306831)
14. Rossi D, Berra E, Cerri M, et al. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma. Haematologica 91(10), 1405-1409 (2006) (Pubitemid 44569818)
15. Montoto S, Davies AJ, Matthews J, et al. Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J. Clin. Oncol. 25(17), 2426-2433 (2007) (Pubitemid 47007616)
16. Armitage JO, Dick FR, Corder MP. Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. Cancer 41(2), 422-427 (1978) (Pubitemid 8289254)
17. Ott MM, Ott G, Roblick U, et al. Localized gastric non-Hodgkin's lymphoma of high-grade malignancy in patients with pre-existing chronic lymphocytic leukemia or immunocytoma. Leukemia 9(4), 609-614 (1995)
18. Ratnavel RC, Dunn-Walters DK, Boursier L, et al. B-cell lymphoma associated with chronic lymphocytic leukaemia: two cases with contrasting aggressive and indolent behaviour. Br. J. Dermatol. 140(4), 708-714 (1999) (Pubitemid 29191395)
19. Parrens M, Sawan B, Dubus P, et al. Primary digestive Richter's syndrome. Mod. Pathol. 14(5), 452-457 (2001) (Pubitemid 32448744)
20. Omoti CE, Omoti AE. Richter syndrome: a review of clinical, ocular, neurological and other manifestations. Br. J. Haematol. 142(5), 709-716 (2008)
21. Bruzzi JF, Macapinlac H, Tsimberidou AM, et al. Detection of Richter's transformation of chronic lymphocytic leukemia by PET/CT. J. Nucl. Med. 47(8), 1267-1273 (2006) (Pubitemid 47544878)
22. Matolcsy A, Chadburn A, Knowles DM. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Am. J. Pathol. 147(1), 207-216 (1995)
23. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103(1), 275-282 (2004) (Pubitemid 38029949)
24. Tsimberidou A-M, O?Brien S, Khouri I, et al. Clinical outcomes and prognostic factors in patients with Richter's syndrome treated with chemotherapy or chemoimmunotherapy with or without stem-cell transplantation. J. Clin. Oncol. 24(15), 2343-2351 (2006) (Pubitemid 46655600)
25. Rossi D, Spina V, Deambrogi C, et al. The genetics of Richter syndrome identifies disease heterogeneity and is an independent predictor of survival post transformation. Presented at: 15th Congress of the European Hematology Association. Barcelona, Spain, 10-13 June 2010
26. Rossi D, Rasi S, Capello D, Gaidano G. Prognostic assessment of BCL2-938C>A polymorphism in chronic lymphocytic leukemia. Blood 111(1), 466-468 (2008)
27. Rossi D, Zucchetto A, Rossi FM, et al. CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia. Haematologica 93(10), 1575-1579 (2008)
28. Rossi D, Spina V, Cerri M, et al. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytc leukemia transformation to Richter syndrome. Clin. Cancer Res. 15(13), 4415-4422 (2009)
29. Rossi D, Lobetti Bodoni C, Genuardi E, et al. Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia. Leukemia 23(6), 1062-1072 (2009)
30. Calin GA, Ferracin M, Cimmino A, et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353(17), 1793-1801 (2005) (Pubitemid 41549891)
31. Kienle DL, Korz C, Hosch B, et al. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes. J. Clin. Oncol. 23(16), 3780-3792 (2005)
32. Klein U, Lia M, Crespo M, et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17(1), 28-40 (2010)
33. Starostik P, Patzner J, Greiner A, et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways. Blood 99(1), 3-9 (2002) (Pubitemid 34532956)
34. Deambrogi C, Cresta S, Cerri M, et al. 14q32 translocations and risk of Richter's transformation in chronic lymphocytic leukaemia. Br. J. Haematol. 144(1), 131-133 (2009)
35. Stamatopoulos K, Belessi C, Moreno C, et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations. Blood 109(1), 259-270 (2007) (Pubitemid 46070124)
36. Bomben R, Dal Bo M, Capello D, et al. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicenter study. Br. J. Haematol. 144(4), 492-506 (2009)
37. Sutton LA, Kostareli E, Hadzidimitriou A, et al. Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen. Blood 114(20), 4460-4468 (2009)
38. Darzentas N, Hadzidimitriou A, Murray F, et al. A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence. Leukemia 24(1), 125-132 (2010)
39. Caligaris-Cappio F, Ghia P. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease? J. Clin. Oncol. 26(27), 4497-4503 (2008)
40. Chu CC, Catera R, Zhang L, et al. Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin. Blood 115(19), 3907-3915 (2010)
41. Del Poeta G, Maurillo L, Venditti A, et al. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood 98(9), 2633-2639 (2001)
42. Ibrahim S, Keating M, Do KA, et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 98(1), 181-186 (2001)
43. Jaksic O, Paro MM, Kardum Skelin I, Kusec R, Pejsa V, Jaksic B. CD38 on B-cell chronic lymphocytic leukemia cells has higher expression in lymph nodes than in peripheral blood or bone marrow. Blood 103(5), 1968-1969 (2004) (Pubitemid 38269003)
44. Deaglio S, Vaisitti T, Aydin S, et al. CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential. Blood 110(12), 4012-4021 (2007) (Pubitemid 350248457)
45. Deaglio S, Capobianco A, Bergui L, et al. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood 102(6), 2146-2155 (2003) (Pubitemid 37122392)
46. Deaglio S, Vaisitti T, Aydin S, Ferrero E, Malavasi F. In-tandem insights from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia. Blood 108(4), 1135-1144 (2006) (Pubitemid 44232007)
47. Patten PE, Buggins AG, Richards J, et al. CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood 111(10), 5173-5181 (2008)
48. Kishimoto H, Hoshino S, Ohori M, et al. Molecular mechanisms of human CD38 gene expression by retinoic acid. Identification of retinoic acid response element in the first intron. J. Biol. Chem. 273(25), 15429-15434 (1998) (Pubitemid 28298149)
49. Ferrero E, Saccucci F, Malavasi F. The human CD38 gene: polymorphism, CpG island, and linkage to the CD157 (BST-1) gene. Immunogenetics 49(7-8), 597-604 (1999) (Pubitemid 29278445)
50. Aydin S, Rossi D, Bergui L, et al. CD38 gene polymorphism and chronic lymphocytic leukemia: a role in Richter syndrome? Blood 111(12), 5646-5653 (2008)
51. Rasi S, Spina V, Bruscaggin A, et al. A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome. Br. J. Haematol. 152(3), 284-294 (2011)
52. Lu D, Zhao Y, Tawatao R, et al. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 101(9), 3118-3123 (2004) (Pubitemid 38327744)
53. Li Y, Pawlik B, Elcioglu N, et al. LRP4 mutations alter Wnt/b-catenin signaling and cause limb and kidney malformations in Cenani-Lenz syndrome. Am. J. Hum. Genet. 86(5), 696-706 (2010)
54. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 266(5193), 2011-2015 (1994)
55. Gaidano G, Ballerini P, Gong JZ, et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc. Natl Acad. Sci. USA 88(12), 5413-5417 (1991) (Pubitemid 21914755)
56. Lee JN, Giles F, Huh YO, et al. Molecular differences between small and large cells in patients with chronic lymphocytic leukemia. Eur. J. Haematol. 71(4), 235-242 (2003) (Pubitemid 37174693)
57. Lo Coco F, Gaidano G, Louie DC, Offit K, Chaganti RS, Dalla-Favera R. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82(8), 2289-2295 (1993) (Pubitemid 23304250)
58. Lossos IS. Higher-grade transformation of follicular lymphoma -a continuous enigma. Leukemia 19(8), 1331-1333 (2005) (Pubitemid 41136323)
59. Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple protooncogenes in B-cell diffuse large-cell lymphomas. Nature 412(6844), 341-346 (2001) (Pubitemid 32691848)
60. Gaidano G, Pasqualucci L, Capello D, et al. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood 102(5), 1833-1841 (2003) (Pubitemid 37022580)
61. Libra M, Capello D, Gloghini A, et al. Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin lymphomas of patients with HCV infection. J. Pathol. 206(1), 87-91 (2005) (Pubitemid 40613438)
62. Klein U, Dalla-Favera R. Germinal centres: role in B-cell physiology and malignancy. Nat. Rev. Immunol. 8(1), 22-33 (2008)
63. Pasqualucci L, Bhagat G, Jankovic M, et al. AID is required for germinal center-derived lymphomagenesis. Nat. Genetics 40(1), 108-112 (2008)
64. Reiniger L, Bödör C, Bognár A, et al. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation. Leukemia 20(6), 1089-1095 (2006) (Pubitemid 43797302)
65. Han T, Sadamori N, Ozer H, et al. Cytogenetic studies in 77 patients with chronic lymphocytic leukemia: correlations with clinical, immunologic, and phenotypic data. J. Clin. Oncol. 2(10), 1121-1132 (1984) (Pubitemid 14022700)
66. Hébert J, Jonveaux P, d?Agay MF, Berger R. Cytogenetic studies in patients with Richter's syndrome. Cancer Genet. Cytogenet. 73(1), 65-68 (1994) (Pubitemid 24205928)
67. Brynes RK, McCourty A, Sun NC, Koo CH. Trisomy 12 in Richter's transformation of chronic lymphocytic leukemia. Am. J. Clin. Pathol. 104(2), 199-203 (1995)
68. Caraway NP, Du Y, Zhang H-Z, Hayes K, Glassman AB, Katz RL. Numeric chromosomal abnormalities in small lymphocytic and transformed large cell lymphomas detected by fluorescence in situ hybridization of fine-needle aspiration biopsies. Cancer 90(2), 126-132 (2000)
69. Santulli B, Kazmierczak B, Napolitano R, et al. A 12q13 translocation involving the HMGI-C gene in Richter transformation of a chronic lymphocytic leukemia. Cancer Genet. Cytogenet. 119(1), 70-73 (2000) (Pubitemid 30254222)
70. Zenz T, Mertens D, Döhner H, Stilgenbauer S. Molecular diagnostics in chronic lymphocytic leukemia -pathogenetic and clinical implications. Leuk. Lymphoma 49(5), 864-873 (2008) (Pubitemid 351942738)
71. Lenz G, Staudt LM. Aggressive lymphomas. N. Engl. J. Med. 362(15), 1417-1429 (2010)
72. Beà S, López-Guillermo A, Ribas M, et al. Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome). Am. J. Pathol. 161(3), 957-968 (2002) (Pubitemid 34988383)
73. Scandurra M, Rossi D, Deambrogi C, et al. Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas. Hematol. Oncol. 28(2), 62-67 (2010)
74. Cohen Y, Da?as N, Libster D, Amir G, Berrebi A, Polliack A. Large-cell transformation of chronic lymphocytic leukemia and follicular lymphoma during or soon after treatment with fludarabinerituximab containing regimens: natural history or related therapy complication. Eur. J. Hematol. 68(2), 80-83 (2002) (Pubitemid 34478271)
75. Thornton PD, Bellas C, Santon A, et al. Richter's transformation of chronic lymphocytic leukemia. The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis. Leukemia Res. 29(4), 389-395 (2005) (Pubitemid 40255812)